Psychiatry and Mental Health
Data update as of 31/12/2025

2025 DATA
Leader
Research
|
LocationDepartment of Psychiatry Avda. Reyes Católicos, 2. 28040 Madrid (Spain). KeywordsMental disorders, depression, schizophrenia, behavioural monitoring, ecological momentary assessment (EMA), and suicide. |
Gender perspective

Summary of activities
In 2025, the Group published numerous scientific articles in peer-reviewed indexed journals, primarily focused on suicide prevention, depression, schizophrenia, artificial intelligence, and the analysis of complex datasets. In addition, the Group secured several competitive grants and research projects. Among these, particular emphasis should be placed on the project "SMARTomicS: Suicide Prevention through Therapeutic Interventions Guided by Digital Phenotyping and Pharmacogenetics", funded under the Research Projects for the Implementation of Personalised Precision Medicine Programme. This project aims to develop innovative strategies for suicide prevention by integrating digital phenotyping tools and pharmacogenetic approaches to support more personalised and effective clinical interventions.
Contributions to society
The Group has contributed to the development of clinical guidelines on suicidal behaviour and has actively participated in research project evaluation committees. In addition, Group members have been involved in public outreach and science communication activities aimed at reducing the stigma associated with mental disorders, particularly that surrounding suicide.
Through these initiatives, the Group seeks to promote awareness, improve mental health literacy, support evidence-based clinical practice, and encourage a more informed and compassionate societal response to mental health conditions and suicidal behaviour
Collaborations
- Icahn School of Medicine, Mount Sinai Hospital (New York, United States).
- Department of Signal Theory and Communications, Carlos III University of Madrid (Madrid, Spain).
- INSERM, University of Montpellier (Montpellier, France).
PhD Theses

List of publications
Emotion Dysregulation, Impulsivity, and Implicit Cognition in Adolescent with Self-Injurious Thoughts and Behaviors: A Six-Month Prospective Study.
Peñuelas-Calvo I, Taracena-Cuerda M, Moreno M, Cabrera-Redondo S, Álvarez-González V, Puente-García R, Quintana-Saiz B, Jiménez-Bidón A, Porras-Segovia A.
J Clin Med. 2025 Dec 09.14(24).
PMID: 41464609
FI: 2,9
http://dx.doi.org/10.3390/jcm14248705
Impact of difficult-to-treat depression for patients and society: a real-world study.
Benavente S, Parra A, Lopez-Castroman J, Conejero I, Alonso-Torres P, López TC, Carrasco Arteaga P, Baca-García E.
Front Psychiatry. 2025.16:1702137.
PMID: 41446298
FI: 3,2
http://dx.doi.org/10.3389/fpsyt.2025.1702137
Use and outcomes of antipsychotic medications for delusional and paranoid personality disorders: A population-based study.
Gonzalo-deMiguel A, Abascal-Peiró S, Prescription Study Group, Martínez-Alés G, Baca-García E.
Schizophr Res. 2025 Dec 22.288:35-37.
PMID: 41435532
FI: 3,5
http://dx.doi.org/10.1016/j.schres.2025.12.010
Leukocytosis and tobacco use during pregnancy.
López Carpintero N, Giráldez-García C, Carmona Camacho R.
Int J Gynaecol Obstet. 2025 Dec 02.
PMID: 41328701
FI: 2,6
http://dx.doi.org/10.1002/ijgo.70670
Obsessive-compulsive and catatonic symptoms in the early stages of psychosis: Are they related?
Sanchez-Alonso S, Canal-Rivero M, Garrido-Torres N, Baca-Garcia E, Crespo-Facorro B, Barrigon ML, Ruiz-Veguilla M.
Eur Arch Psychiatry Clin Neurosci. 2025 Dec.275(8):2523-2533.
PMID: 41051428
FI: 3,7
http://dx.doi.org/10.1007/s00406-025-02080-2
Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects.
Mora F, Ramos-Quiroga JA, Baca-García E, Crespo JM, Gutiérrez-Rojas L, Madrazo A, Pérez Costillas L, Saiz PA, Tordera V, Vieta E.
Front Psychiatry. 2025.16:1623659.
PMID: 40838256
FI: 3,2
http://dx.doi.org/10.3389/fpsyt.2025.1623659
Depression subtypes, suicidality, and healthcare costs in older adults: results from a naturalistic study.
Conejero I, Porras-Segovia A, Albarracín-García L, Barrigón ML, Lopez-Castroman J, Courtet P, Baca-Garcia E.
Front Psychiatry. 2025.16:1560719.
PMID: 40599227
FI: 3,2
http://dx.doi.org/10.3389/fpsyt.2025.1560719
One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians.
Manchado Perero S, Rodríguez Lorente A, García-Pérez A, Isidro García G, Forcen-Muñoz LA, Ovejero S, Sáez Povedano R, González-Galdámez AL, Iturralde LM, Bonilla MR, Fuentes-Pérez P, Ovejas-Catalán C, Suárez-Pinilla P, Fernandez Abascal Puente B, Omaña Colmenares M, Campos-Navarro MP, Baca-García E, Fernández AL, Benavente-López S, Platero AR, Navalón MB, Sánchez-Alonso S, Vázquez-Bourgon J, Pappa S, García-Carmona JA.
Patient Prefer Adherence. 2025.19:1573-1582.
PMID: 40458740
FI: 2
http://dx.doi.org/10.2147/PPA.S517038
Long-term effectiveness, adherence and safety of twice-yearly paliperidone-palmitate long acting-injectable in patients with schizophrenia in Europe: 2-year mirror-image data from the paliperdone-2 per year study (P2Y).
Manchado Perero S, Rodríguez Lorente A, García-Pérez A, Isidro García G, Forcen-Muñoz LA, Ovejero García S, Sáez Povedano R, González-Galdámez AL, Mata Iturralde L, Ramirez Bonilla M, Fuentes-Pérez P, Ovejas-Catalán C, Suárez-Pinilla P, Fernández Abascal B, Omaña Colmenares M, Campos-Navarro MP, Baca-García E, Lara Fernández A, Benavente-López S, Raya Platero A, Barberán Navalón M, Sánchez-Alonso S, Vázquez-Bourgon J, Pappa S, García-Carmona JA.
Front Psychiatry. 2025.16:1540213.
PMID: 40104335
FI: 3,2
http://dx.doi.org/10.3389/fpsyt.2025.1540213
Psychiatry at the turn of the century and a vision for future developments.
Oquendo MA, Barrigon ML, Baca-Garcia E.
Int Rev Psychiatry. 2025 Nov 19:1-15.
PMID: 41258672
FI: 3,4
http://dx.doi.org/10.1080/09540261.2025.2591200
Association Between Trauma, Impulsivity, and Functioning in Suicide Attempters.
Escobedo-Aedo PJ, Porras-Segovia A, Barrigón ML, Courtet P, López-Castroman J, Baca-Garcia E.
Behav Sci (Basel). 2025 Sep 15.15(9).
PMID: 41009292
FI: 2,5
http://dx.doi.org/10.3390/bs15091262
The Relation Between Violence and Suicidality in Mexico: The Impact of Different Types of Violence in Suicidal Behaviour Detected by a Massive Mental Health Screening App (MeMind).
Molina-Pizarro CA, Lopez-Fernandez O, Villasante-Soriano P, Martinez-Nicolas I, Aroca-Bisquert F, Méndez-Bustos P, Giner L, Baca-García E.
Behav Sci (Basel). 2025 Aug 18.15(8).
PMID: 40867474
FI: 2,5
http://dx.doi.org/10.3390/bs15081117
Esketamine use in real-world clinical practice in patients with treatment-resistant depression.
Conejero I, Alvarez García R, Porras-Segovia A, De Granda Beltrán AM, Benavente López S, Di Stasio E, Albarracín-García L, Lopez-Castroman J, Courtet P, Baca-Garcia E, Memind Group.
Eur Psychiatry. 2025 Aug 26.68(1):e158.
PMID: 40856202
FI: 6,7
http://dx.doi.org/10.1192/j.eurpsy.2025.10096
Impulsivity and aggression in suicide across age and sex: case-control study.
Sanz-Gómez S, Vera-Varela C, de-la-Vega-Sánchez D, Barrigón ML, Alacreu-Crespo A, Guija JA, Sánchez A, de León S, Baca-García E, Giner L.
BJPsych Open. 2025 Aug 01.11(5):e167.
PMID: 40744472
FI: 3,5
http://dx.doi.org/10.1192/bjo.2025.10076
Executive function and quality of life in children and adolescents with type 1 diabetes: The mediating role of the Child Behavior Checklist Dysregulation Profile.
Martin-Martinez N, Caro-Cañizares I, Carballo JJ, Parellada M.
Eur J Pediatr. 2025 Jun 25.184(7):446.
PMID: 40560466
FI: 2,6
http://dx.doi.org/10.1007/s00431-025-06266-7
Impact of Digital Safety Plan Activation on Subsequent Emergency Departments Visits Following an Initial Suicide Attempt: Quasi-Experimental Study.
Barrigón ML, Schmidt C, Elices M, Porras-Segovia A, De Granda-Beltrán AM, Artés-Rodríguez A, Courtet P, Pérez-Sola V, Baca-García E.
JMIR Ment Health. 2025 Jun 17.12:e70253.
PMID: 40526825
FI: 5,8
http://dx.doi.org/10.2196/70253
Feasibility of digital monitoring in patients receiving ambulatory psychiatric care.
Conejero I, Villalba MÁ, Matos V, Jiménez O, García R, Albarracín-García L, Porras-Segovia A, Barrigón ML, Lopez-Castroman J, Artés-Rodriguez A, Baca-Garcia E.
J Psychiatr Res. 2025 May 28.189:184-192.
PMID: 40516300
FI: 3,2
http://dx.doi.org/10.1016/j.jpsychires.2025.05.072
Multiple emergency department visits and suicidal behavior in children and adolescents.
Merayo-Cano JM, Porras-Segovia A, Taracena-Cuerda M, García SM, Marti-Estevez I, Carrillo-Notario L, Martinez-Martín N, Álvarez-García R, Baca-García E, Peñuelas-Calvo I.
J Psychiatr Res. 2025 May.185:84-92.
PMID: 40168743
FI: 3,2
http://dx.doi.org/10.1016/j.jpsychires.2025.03.029
Characteristics of Self-Harm in an Emergency Situation Among Youth: A Longitudinal Five- Year Cohort Study.
Varo C, Barrigón ML, Rider J, Reguera P, Mayo-Jaraquemada A, Canal-Rivero M, Garrido-Torres N, Baca-Garcia E, Ruiz-Veguilla M, Crespo-Facorro B.
Res Child Adolesc Psychopathol. 2025 Apr 26.
PMID: 40285950
FI: 2,4
http://dx.doi.org/10.1007/s10802-025-01309-x
The Implementation of Shared Decision-Making Using Patient Decision Aid Tools to Select Breast Cancer Treatment Options: A Systematic Review in the Time of Minimum Quality Standards.
Lopez-Fernandez O, Aguilar Castillo CP, Horrillo B, Sánchez de Molina Ramperez ML, Guadalajara H.
Healthcare (Basel). 2025 Mar 27.13(7).
PMID: 40218046
FI: 2,7
http://dx.doi.org/10.3390/healthcare13070748
Reflections on the Potential and Risks of AI for Scientific Article Writing after the AI Endorsement by Some Scientific Publishers: Focusing on Scopus AI.
De Leon J, De Leon-Martinez S, Artés-Rodríguez A, Baca-García E, De Las Cuevas C.
Actas Esp Psiquiatr. 2025 Mar.53(2):433-442.
PMID: 40071362
FI: 1,6
http://dx.doi.org/10.62641/aep.v53i2.1849
Predictors of Suicide Attempts and Reattempts in a Sample of Chilean Adolescents.
Escobedo-Aedo PJ, Méndez P, Álvarez R, Baca-García E, Porras-Segovia A.
Early Interv Psychiatry. 2025 Mar.19(3):e70024.
PMID: 40050958
FI: 2,2
http://dx.doi.org/10.1111/eip.70024
Artificial intelligence in healthcare: Revolution or unfulfilled promise?
Anmella G, Baca-García E.
Eur Neuropsychopharmacol. 2025 Feb 15.94:1-3.
PMID: 39956012
FI: 6,7
Projects, contracts and observational studies
PUBLICS
Sources of public funding for projects being developed at the IIS-FJD:

|
REFERENCE |
PROJECT TITLE |
PRINCIPAL RESEARCHER |
TYPE OF PROJECT |
TOTAL FUNDING |
|
PI23/00614 |
SURVIVE 2: UN ESTUDIO DE COHORTE EXTENDIDA PARA INVESTIGAR LA CONDUCTA SUICIDA EN ESPAÑA Y LA EFICACIA DE ESTRATEGIAS DE PREVENCIÓN SECUNDARIA. SUB-PROYECTO 2. FENOTIPO DIGITAL DE LA CONDUCTA SUICIDA. |
BACA GARCIA, ENRIQUE |
CLINICAL RESEARCH PROJECTS. ISCIII |
€147,500.00 |
|
PMP24/00026 |
SMARTOMICS: PREVENCIÓN DE LA CONDUCTA SUICIDA MEDIANTE INTERVENCIONES TERAPEÚTICAS GUIADAS POR FENOTIPO DIGITAL Y FARMACOGENÉTICA: ENSAYO CLÍNICO ALEATORIZADO PARA EVALUAR LA EFECTIVIDAD EN LA PREVENCIÓN DE LA CONDUCTA SUICIDA DE INTERVENCIONES TERAPÉUTICAS GUIADAS POR FENOTIPO DIGITAL Y FARMACOGENÉTICA. |
BACA GARCIA, ENRIQUE |
CLINICAL TRIALS WITH OTHER PRODUCTS OR PROCEDURES. ISCIII |
€3,541,874.49 |
|
S2022/BMD-7216 |
AMBIENTE Y GENES EN ESQUIZOFRENIA (AGES-CM 3) |
BACA GARCIA, ENRIQUE |
CLINICAL RESEARCH PROJECTS. CAM |
€36,800.00 |
|
TEC-2024/COM-224 |
PROYECTO ALENTAR-J-CM: APLICACIÓN DE MODELOS DEL LENGUAJE A GRAN ESCALA PARA LA PREVENCIÓN SOCIOSANITARIA DE PROBLEMAS DE SALUD MENTAL Y RIESGO DE SUICIDIO EN JÓVENES |
BACA GARCIA, ENRIQUE |
CLINICAL RESEARCH PROJECTS. CAM |
€72,145.78 |
|
JR22/00011 |
CONTRATO JUAN RODÉS: ALEJANDRO PORRAS SEGOVIA. |
PORRAS SEGOVIA, ALEJANDRO |
POSTDOCTORAL RESEARCH. ISCIII |
€180,000.00 |
PRIVATE
|
REFERENCE |
PROJECT TITLE |
PRINCIPAL RESEARCHER |
TYPE OF PROJECT |
|
202226-31 |
A MULTI-SITE-TWO-YEAR FOLLOW-UP STUDY OF THE SURVIVE COHORT: PREVENTING SUICIDE USING A SMARTPHONE-BASED ECOLOGICAL MOMENTARY INTERVENTION (SURVIVE-SMART) |
BACA GARCIA, ENRIQUE |
RESEARCH PROJECTS. COMPETITIVE |
|
HR23-00421 |
MULTISITE SMARTPHONE-BASED ECOLOGICAL MOMENTARY INTERVENTION FOR SUICIDE PREVENTION |
BACA GARCIA, ENRIQUE |
RESEARCH PROJECTS. COMPETITIVE |
|
7931/001 |
PLAN DE SEGURIDAD DIGITAL PARA LA PREVENCIÓN DE LAS CONDUCTAS SUICIDA Y AUTOLESIVA EN ADOLESCENTES (SMARTCRISIS-TEEN) |
PORRAS SEGOVIA, ALEJANDRO |
RESEARCH PROJECTS. COMPETITIVE |
|
ECR-1-101-23 |
EFFECTIVENESS OF PHARMACOLOGICAL INTERVENTIONS TO PREVENT SUICIDAL BEHAVIORS AMONG INDIVIDUALS AT HIGH SUICIDE RISK: A TARGET TRIAL EMULATION |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES. COMPETITIVE |
|
2024.089 |
PREVENCIÓN E INTERVENCIÓN PRECOZ EN PACIENTES CON RIESGO SUICIDA |
BACA GARCIA, ENRIQUE |
RESEARCH PROJECTS |
|
2024.093 |
PREVENCIÓN E INTERVENCIÓN PRECOZ EN PACIENTES CON RIESGO SUICIDA |
BACA GARCIA, ENRIQUE |
RESEARCH PROJECTS |
|
EO071-21_FJD |
ITINERARIOS DE CUIDADO DEL TRASTORNO DEPRESIVO A TRAVÉS DE LA BDD MEMIND. EL PAPEL DE URGENCIAS |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES |
|
EO266-24_FJD |
IMPACT OF PPLATS ON CLINICAL OUTCOMES IN SCHIZOPHRENIA THROUGH MEMIND DB - THE ROLE OF ANTIPSYCHOTICS WITH LONGER INTERVAL OF ADMINISTRATION |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES |
|
EOH009-23_HRJC |
ESTUDIO OBSERVACIONAL, NATURALÍSTICO, TRANSVERSAL PARA DESCRIBIR EL USO DE ESKETAMINA EN PULVERIZADOR NASAL EN LA DEPRESIÓN RESISTENTE AL TRATAMIENTO EN PRÁCTICA CLÍNICA REAL.ESTUDIO INTEGRATE |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES |
|
EOH017-24_FJD |
ESTUDIO DE LAS CARACTERÍSTICAS DE LA ENFERMEDAD Y LA EFICACIA DEL TRATAMIENTO HABITUAL EN LA VIDA REAL EN PACIENTES CON TRASTORNO DEPRESIVO MAYOR (TDM) CON ANHEDONIA Y RESPUESTA INADECUADA AL TRATAMIENTO ANTIDEPRESIVO ACTUAL, INCLUIDO UN ISRS O UN IRSN – ESTUDIO VENTURA RWE |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES |
|
EOH045-25_FJD |
ESTUDIO COHORTES, NO INTERVENCIONISTA, PROSPECTIVO, DE PRACTICA REAL PARA EVALUAR LA REMISIÓN FUNCIONAL EN PACIENTES CON TRD TRATADOS CON ESKETAMINA INTRANASAL |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES |
|
EOH045-25_HGV |
ESTUDIO COHORTES, NO INTERVENCIONISTA, PROSPECTIVO, DE PRACTICA REAL PARA EVALUAR LA REMISIÓN FUNCIONAL EN PACIENTES CON TRD TRATADOS CON ESKETAMINA INTRANASAL |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES |
|
EOH045-25_HIE |
ESTUDIO COHORTES, NO INTERVENCIONISTA, PROSPECTIVO, DE PRACTICA REAL PARA EVALUAR LA REMISIÓN FUNCIONAL EN PACIENTES CON TRD TRATADOS CON ESKETAMINA INTRANASAL |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES |
|
EOH045-25_HRJC |
ESTUDIO COHORTES, NO INTERVENCIONISTA, PROSPECTIVO, DE PRACTICA REAL PARA EVALUAR LA REMISIÓN FUNCIONAL EN PACIENTES CON TRD TRATADOS CON ESKETAMINA INTRANASAL |
BACA GARCIA, ENRIQUE |
OBSERVATIONAL STUDIES |
|
EOH007-24_HIE |
PREVALENCE OF ADHD AND HEALTH OUTCOMES IN ADULT OUTPATIENTS WITH PSYCHIATRIC DISORDERS: A MULTI-COUNTRY, TWO-PART, OBSERVATIONAL STUDY. |
BENAVENTE LOPEZ, SERGIO |
OBSERVATIONAL STUDIES |
|
EOH039-23_HRJC |
RISPERIDONE ISM® EFFECTIVENESS IN SCHIZOPHRENIA PATIENTS HOSPITALISED DUE TO A RELAPSE: A PROSPECTIVE NON-INTERVENTIONAL EVALUATION |
RENOVELL BUENO, IRENE |
OBSERVATIONAL STUDIES |
|
PIC052-23_FJD |
ESTUDIO DE COHORTES NO INTERVENCIONISTA SOBRE EL AEROSOL NASAL DE ESKETAMINA EN LA DEPRESIÓN RESISTENTE AL TRATAMIENTO – "ECHO" |
BACA GARCIA, ENRIQUE |
RESEARCH PROJECTS |
Clinical trials
The clinical trials listed below were in the recruitment phase in 2025. If you are interested in participating in any of the currently open trials, more information is available on the website (https://ensayos.quironsalud.es/)
|
EudraCT Number |
TITLE |
PHASE |
MC1 |
INT2 |
PRINCIPAL RESEARCHER |
|
2020-003744-84 |
ESTUDIO DE FASE III, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE ICLEPERTIN UNA VEZ AL DÍA DURANTE UN PERIODO DE TRATAMIENTO DE 26 SEMANAS EN PACIENTES CON ESQUIZOFRENIA (CONNEX-2) |
III |
YES |
YES |
ENRIQUE BACA GARCIA |
|
2020-003745-11 |
ESTUDIO DE EXTENSIÓN, ABIERTO, DE UN ÚNICO GRUPO, PARA ESTUDIAR LA SEGURIDAD A LARGO PLAZO DE BI 425809, UNA VEZ AL DÍA, EN PACIENTES CON ESQUIZOFRENIA QUE HAYAN COMPLETADO UN ESTUDIO PREVIO DE FASE III DE BI 425809. (CONNEX-X) |
III |
YES |
YES |
ENRIQUE BACA GARCIA |
|
2022-002339-73 |
ESTUDIO EN FASE III, MULTICÉNTRICO, CONTROLADO, ALEATORIZADO Y CON ENMASCARAMIENTO DOBLE PARA INVESTIGAR LA EFICACIA, LA SEGURIDAD Y LA TOLERABILIDAD DE DOS ADMINISTRACIONES DE COMP360 EN PARTICIPANTES QUE SUFREN DEPRESIÓN RESISTENTE AL TRATAMIENTO |
III |
YES |
YES |
ENRIQUE BACA GARCIA |
|
2023-509070-36-00 |
A TWO-PART MULTICENTER, DOUBLE-BLIND, RANDOMIZED PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY AND THE MAINTENANCE OF EFFECT OF 20-MG SELTOREXANT AS ADJUNCTIVE THERAPY TO ANTIDEPRESSANTS IN ADULT AND ELDERLY PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH INSOMNIA SYMPTOMS |
III |
YES |
YES |
ENRIQUE BACA GARCIA |
|
NA |
SMARTOMICS: PREVENCIÓN DE LA CONDUCTA SUICIDA MEDIANTE INTERVENCIONES TERAPEÚTICAS GUIADAS POR FENOTIPO DIGITAL Y FARMACOGENÉTICA: ENSAYO CLÍNICO ALEATORIZADO PARA EVALUAR LA EFECTIVIDAD EN LA PREVENCIÓN DE LA CONDUCTA SUICIDA DE INTERVENCIONES TERAPÉUTICAS GUIADAS POR FENOTIPO DIGITAL Y FARMACOGENÉTICA. |
IV |
YES |
NO |
BACA GARCIA, ENRIQUE |
|
NA |
PLATAFORMA DIGITAL PARA LA EVALUACIÓN Y PREVENCIÓN DE LAS CONDUCTAS SUICIDA Y AUTOLESIVA EN ADOLESCENTES (SMARTCRISIS-TEEN) |
NA |
YES |
NO |
ALEJANDRO PORRAS SEGOVIA |
|
NA |
EVALUACIÓN DE LAS AUTOLESIONES Y PREVENCIÓN DEL RIESGO EN PERSONAS JÓVENES |
NA |
YES |
NO |
ALEJANDRO PORRAS SEGOVIA |
|
NA |
EFECTIVIDAD DE UNA INTERVENCIÓN ECOLÓGICA MOMENTÁNEA MEDIANTE SMARTPHONES PARA LA PREVENCIÓN DE LA CONDUCTA SUICIDA: ENSAYO CLÍNICO ALEATORIZADO (SMARTCRISIS 3.0) |
NA |
YES |
NO |
ENRIQUE BACA GARCIA |
|
MC1: MULTICENTRE INT2: INTERNATIONAL |
|||||










